Tate & Lyle plc (TATE) Earnings Call Transcript & Summary

May 23, 2024

London Stock Exchange GB Consumer Staples Food Products earnings 21 min

Earnings Call Speaker Segments

Nick Hampton

executive
#1

Good morning, everyone, and thank you for joining today's full year results presentation. We are now into the live Q&A. As I said in the prerecording, we delivered robust performance in the year with strong profit growth and cash generation and significant strategic progress, while successfully navigating a challenging external environment. Following the sale of the remaining stake in Primient, Tate & Lyle is now a fully focused specialty business creating solutions that meet growing consumer demand for healthier, tastier and more sustainable food and drink. At the completion of the transaction, we will return the net proceeds to shareholders through a share buyback program.

Nick Hampton

executive
#2

Turning now to your questions. The first question comes from Damian McNeela at Deutsche Numis.

Damian McNeela

analyst
#3

Just 2 for me, please. Just on the EBITDA growth for this year. Can you just sort of talk about the considerations around volume expectations that is being incorporated into that? And then on the longer-term sort of EBITDA growth ambitions. Do you still think you can hit that sort of 7% to 9% over the 5-year time frame that you set last year? And then the second question is just on the volume performance. I think you've talked about an improving volume performance so far, well, in Q4 and then a bit into this year. Can you just give any more color on whether there are any sort of particular categories or channels which are seeing the growth and whether there any laggards that you would expect to recover as we go through the year, please?

Nick Hampton

executive
#4

Sure. Both very good questions, Damian. Let me take the first one and then maybe Dawn can add some more color on the volumes. So as we thought about guidance for this year, I'd say a few things. Firstly, we're clearly seeing positive signs of recovery in the market. And we saw that in the last quarter of the last financial year. And as we built our plan for this year, we were really looking to balance a few things. The first is signs of recovery, both with customers and with consumers. So with customers, we're seeing an entity stocking, we're seeing some more positive views of the future, and we're seeing increased engagement on innovation. That's all good. And a view that things are going to recover through this year as consumer confidence improves because of the improving economic environment in general around the world. So we're balancing off a view of seeing improved volume performance because of the fundamentals in the market. On top of that, a positive contracting round. Alongside that, we're trying to continue to make sure we invest in the future growth of the business. We've been very, very consistent through the last 3 or 4 years despite all the economic volatility, investing in innovation, investing in solution selling, investing in capacity, investing in in-market capability to serve customers. And you saw that again last year. So we will continue to invest. And the range of our guidance reflects the fact that we want to see how volume improves through the year. It was still early in the year. So that's the first part of your question. The second part is absolutely we believe we can hit our medium-term guidance. If you look at the last 3 years, we delivered double-digit revenue and EBITDA performance, which underpins that confidence. We're just coming into this year, we're trying to balance off an improving economic environment with continuing to invest for the future so that we can successfully continue to deliver what we've done in the last 3 years. So Dawn, I don't know whether you want to add something on the volume color?

Dawn Allen

executive
#5

Well, I think that maybe a couple of things just to build on the EBITDA. So we've delivered 10% EBITDA growth over the last 3 years. So if you add in the -- if you add in our outlook for this year, we'll still be towards the top of our long-term range. So I think that's a very strong performance. I think in terms of the volume, as Nick talked about, we are seeing small pockets of volume growth. Clearly, it's different across the different geographies and different categories around the world. So stronger performance starting to come through in beverages, particularly in places like nonalcoholic beverages as well as dairy. And I think particularly in China and in the U.S., consumer confidence is still -- we're still looking and waiting for that to improve. But as we talked about, we expect volume performance, and Nick talked about it. We expect that to continue to improve throughout the year and accelerate as we move through.

Nick Hampton

executive
#6

So our next question is from Alex Sloane at Barclays.

Alexander Sloane

analyst
#7

The first one, just in terms of the price resets for 2024 reflecting, in part, lower input costs. I think the statement still refers to some competition in FBS in Latin America and Europe. Obviously, you talked about that earlier last year. Have you seen any easing on this front with the new reset prices? That would be the first question. And the second one, just going back to the question on volume. I think you had said in quarter 3, maybe there was a 3-point impact from destocking into the year-end, which you expect it to reverse in the first quarter. If I look at the first quarter -- sorry, in the fourth quarter, in the calendar first quarter, if I look at the volumes in quarter 4, it looks like maybe excluding that phasing benefit, they were still slightly negative. So I just wondered, is there any sort of worsening in the trends as you exited the quarter? And just be interested in terms of what you've already seen in April and May on this front, presumably, values are improving to give you the confidence in the full year outlook.

Nick Hampton

executive
#8

So maybe I'll take the first question -- the second question first, and I'll come back to the pricing point. So yes, we saw a sequential improvement in volume as we went into the fourth quarter. I'd say if you take into -- the sort of residual impact of destocking as we entered the last quarter of our financial year, we clearly saw an improvement in volume run rates. And as we come into the first part of this financial year, we're starting to see that continue as well. So we're definitely seeing some positive momentum that is both about exiting the destocking. It's also about exiting the period of when we were exiting low-margin business, and it reflects the positive signs we saw in the contract round along the market evolution that we talked about earlier. So we're definitely seeing improvement as we come into the first quarter of this year. So that's all very consistent actually with what we said in our Q3 statement. That's all that's all good. In terms of the pricing reset, it varies by geography, clearly. We're probably seeing net-net a slight easing rather than an acceleration of the trends that you mentioned. But they're clearly still there in pockets of the business, and we need to make sure we balance the price, price revenue margin to reflect the relative competitive dynamics across the world. So hopefully, that gives you a broad sense, Alex, if what we're seeing on your 2 questions. And our next question comes from Karel Zoete of Kepler Cheuvreux.

Karel Zoete

analyst
#9

I've got 2 questions. The first one is on mix, mix improvements in the second half of the year. It seems that has slowed quite a bit. Part of it anticipated. But if you can speak a bit about the mix trends during the second half of the year. And the other thing is looking at the cost situation, a very good savings momentum. In general, I think the outlook for cost of goods sold, but also other cost lines is more favorable than 12 months ago. So if you can touch upon that. And obviously, that also comes back to the EBITDA guidance as -- yes. It seems there is good savings momentum in the business. Volumes will recover. So yes, much appreciated.

Nick Hampton

executive
#10

So why don't I take the second question and then Dawn can maybe pick up on the mix point. So as you rightly say, Karel, I mean, 2 headlines, I would say, on cost. Incredibly pleased with the discipline the team is bringing to productivity. So $40 million plus productivity last year and that reflects a systemic program, but also some of the investments we're making in systems to allow us to get more efficient at predicting and planning the business and managing our end supply chain and serving our customers better. And that's reflected in the fact that we've called up our productivity guidance for the 5-year period, so from $100 million to $150 million. So the team doing a really good job there. Of course, we're also seeing the impact of inflation easing on input costs as well. And that delivers that delivers some significant benefits this year, which as we've done -- as we did with inflationary pressures, we're passing through to customers in a responsible way. They were accepting of price increases when we were under inflationary pressures because of the value we bring to their products. And we were committed to being fair with them as inflation abated. So that's reflected in the pricing dynamics in the business as we've given guidance on revenue for this year. Now when you add all of that up, though and you think about the shape of our EBITDA guidance, it really reflects the balance between being really disciplined on cost and productivity, but also continuing to invest in the long-term future of the business in innovation, in solution selling and customer intimacy. And as we add all of that up and look at the volume trajectory, that's where we end up with EBITDA guidance that sort of touches the end of our long-term range. So Dawn, do you want to pick up mix?

Dawn Allen

executive
#11

Yes. So Karel, if you remember, in the first half of last year, we did have very strong price mix. Obviously, at the half year, we had 13 points of price mix, roughly driven half inflation and half price mix. As we moved into quarter 3, we saw a similar trend, but it came off slightly. And then as we moved into quarter 4 and we set the new contracting round. And as we've talked about, we've set up that contracting round to drive volume growth. We also moved into a deflationary environment. So high single-digit deflation in quarter 4. We also selectively chose to invest with specific customers to drive long-term growth, but that is a small impact in the quarter. And as we look forward, we would expect to see high single-digit deflation particularly in the first half of the year. And as the volume momentum improves, we expect that to start to offset and more than offset as we move through the year, the selective investment that we've chosen to do with some customers.

Nick Hampton

executive
#12

Okay. So our next question is from Chris Pitcher at Redburn.

Chris Pitcher

analyst
#13

A couple of questions for me on the sort of the momentum in innovations and solutions selling. You increased spend by a double-digit rate in the first half. It was up 5% for the full year. So it's kind of flat in the second half. Is that because you've got to sort of level that you think is sustainable? And could you give a bit more color on what your R&D spend is doing? And then I appreciate it's modest changes, but the percentage of new business wins went down a bit at the full year versus the first half. I'm just wondering what's going on in the background. And last one, are you able to give us an absolute share of your business between what draft at the CMD between specification, technical sports and solutions? What is solutions actually the underlying business? I understand that the goal to get the new wins up to over 30%. But just I -- just clarify where we are on the base?

Nick Hampton

executive
#14

So let me try and take those 3 questions in turn. So I would think about the investment level in innovation, solution selling R&D, the 5% in the year. I would just think of it as a phasing impact half 1, half 2. It doesn't really reflect any slowdown. And it certainly doesn't reflect that we think we've reached the limit of where we want to be. So we're going to continue to commit to delivering at least 5% increase in spend on innovation and solution selling and customer intimacy through the next few years. So it's not a sign of any slowdown. It's just a phasing impact to half 1, half 2. In terms of kind of solution selling, as percentage of wins. Again, we're up 3 points in the year at 21%. That's the real message. And of course, it's going to vary a little bit quarter-on-quarter. And importantly, in that 21% nearly half of that came from new products. So our new products are really starting to have an impact on the business. We said before that in broad terms, if you think about what -- how much of that business is actually in solution selling today, it's around about 20% in round terms. It's growing. And that's good news because that means there's plenty to go after in terms of improving that proportion as part of the business. And as we said before, that business is really valuable because it tends to be bigger pieces of business. It tends to be stickier because we're formulating into the critical part of the product. And it builds relationships, which leads to more business. So lots more to go after. We're going to continue to invest with intent to make sure we're managing the shape of the business for the future.

Chris Pitcher

analyst
#15

I've got a follow-up but someone else is on the line looking to question. So I mean can I quickly ask, I mean CapEx is lower than the trend you said previously for this year. Is this a phasing effect? Or do you think you can drive growth at lower investments?

Nick Hampton

executive
#16

Dawn, do you want to take that?

Dawn Allen

executive
#17

Yes. So I would say -- I mean, CapEx at GBP 110 million is GBP 39 million up versus the previous year. So I'd say that we are continuing to invest in CapEx. And a good example of that is our new fibers line in Boleráz, that's just recently come on stream. I think if you think about -- in terms of capital markets, you're right, we did talk about an increasing CapEx spend going up to the region of GBP 130 million to GBP 150 million. If you think about what's happened over the last 12 months with low consumer confidence and destocking, there hasn't been as much of a need to invest in growth CapEx given that more than half of our CapEx is spent on growth investments. But when you look to next year, I mean, our forecast for CapEx for next year is in the range of GBP 100 million to GBP 120 million. So we are actually increasing to get to that long-term range that we talked about. But it's still a key growth driver and a key investment driver for us.

Nick Hampton

executive
#18

And Chris, I'd probably just add one point to that, which is -- we've been very focused in the last really 5 or 6 years to try and increase the quality of the business. And part of the benefits of that is you get more out of your existing assets, and you could be more efficient with your capital spend. That's reflected in where our return on capital is, it's just reflected in the progress in our EBITDA margins. And it's reflected in the strength of the balance sheet. So we've got plenty of firepower to invest, but we want to continue to invest to drive maximum returns. So should we move on? And our next question comes from Joan Lim from BNP Exane. Joan?

Yuan Lim

analyst
#19

Hello. Can you hear me?

Nick Hampton

executive
#20

Yes, we can.

Yuan Lim

analyst
#21

Perfect. Two questions from me, please. So your leverage is still strong even after the share buyback. Why did you not do a bigger share buyback?

Nick Hampton

executive
#22

So you said you had 2 questions, Joan?

Yuan Lim

analyst
#23

Yes. Shall I ask...

Nick Hampton

executive
#24

Yes. Give us a second one as well.

Yuan Lim

analyst
#25

Okay. And then your FY '25 guidance, it looks conservative to that 4% to 7%, given that you think volumes are going to improve and then prices pass through is there anything, I don't know, maybe for Q1 trends you've seen so far or is there scope for an upgrade to your guidance very -- maybe too early. But so if you could just help us understand a bit more into the drivers of this guidance?

Nick Hampton

executive
#26

So let me take the first question and then come back -- we'll come back to the second one. So look, on the buyback. We've announced we're going to return all the net proceeds from the sale of our final stake in Primient to shareholders. Do you think that's a responsible thing to do with the excess cash that we're bringing in as a result of that transaction. As we've demonstrated in the past, we will hand back cash to shareholders as appropriate. But our capital allocation policy is very clear. We want to maintain the scope to invest both inorganically and organically. And we want to make sure that we're paying an appropriate dividend to our shareholders. And on top of that, we'll continue to reevaluate returning capital. We're not saying that that's necessarily the last thing we're going to do, but it feels like a very sensible position to take as we speak today. On your point on conservatism on guidance, look, I think we've been very clear we're starting to see improvements in volume momentum. We're starting to see economic recovery around the world and a sense of consumer confidence increasing but still fragile. And we want to continue to invest in the business. So that's why the 4% to 7% guidance feels appropriate today. We'll be in a much better position to give you a view on where we are on that when we get to a half year, and we'll see how economies develop and the business develops over the next 6 months. So for now, we think it's the right way to calibrate a business that, by the way, has delivered double-digit EBITDA growth over the last 3 years pretty consistently. And whether that's conservative or not, we'll have a better view on at the half year, frankly. So I think we've come to end of our questions. So thank you to everyone for watching and for all of your questions. In summary, we delivered good performance in the year with strong profit growth in line with our guidance and excellent cash generation. The sale of our remaining stake in Primient completes the transformation of Tate & Lyle into a specialty solutions provider to the food and beverage industry. We will continue to progress our growth focus strategy and remain well placed to benefit from the long-term trends towards healthier, tastier and more sustainable food and drink. Thank you all for your time, and I wish you all a very good day.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Tate & Lyle plc transcript — plus 250,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Tate & Lyle plc earnings transcripts and 250,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.